Skip to main content

Table 2 Dose groups, substances and dosing

From: The carcinogenic effect of various multi-walled carbon nanotubes (MWCNTs) after intraperitoneal injection in rats

Substance

Carbon source

Catalyst

Generation method

Length (μm) all fibers

Length (μm) WHO fibers*

Diameter (μm) WHO fibers*

Specific fiber concentration (109WHO fibers*/mg)

Fibers [length >20 μm] (% of WHO fibers*)

Dose WHO fibers* 109per rat (targeted#)

Dose WHO fibers 109per rat (actual##)

Dose (mg in 2 ml)###

Inner angle

No. of rats

Medium control

-

-

-

-

-

-

-

-

-

-

-

-

50

MWCNT A low

Benzene

Fe

Sublimation method

2.72 ± 2.29

8.57 ± 1.51

0.085 ± 1.60

2.39

3.81

1

0.48

0.2

174.85°±5.82°

50

MWCNT A high

5

2.39

1.0

50

MWCNT B low

Cyclohexane

Fe

Aerosol method

2.13 ± 2.46

9.30 ± 1.63

0.062 ± 1.71

1.60

9.35

1

0.96

0.6

148.10°±11.48°

50

MWCNT B high

5

4.80

3.0

50

MWCNT C low

Cyclohexane

Fe

Aerosol method

4.18 ± 2.41

10.24 ± 1.64

0.040 ± 1.57

10.91

11.77

1

0.87

0.08

144.55°±11.48°

50

MWCNT C high

5

4.36

0.4

50

MWCNT D low

Acetonitrile

Co

Aerosol method

2.53 ± 2.02

7.91 ± 1.40

0.037 ± 1.45

30.15

2.13

1

1.51

0.05

Not measured

50

MWCNT D high

5

7.54

0.25

50

Long amosite asbestos

-

-

-

6.22 ± 3.12

13.95 ± 2.10

0.394 ± 1.83

0.1

28.55

0.1

0.14

1.4

-

50

  1. Fiber types, lengths and diameters (geometric mean, GMSTD), % of WHO fibers* (length greater than 20 μm) and inner angles (to evaluate the degree of circumflexion of the different CNTs, the angle at the concave side [inner angle] was measured between two straight lines, the first from the beginning of the circumflexion to the middle and the second from the middle to the end of the circumflexion).
  2. *WHO fibers: length greater than 5 μm, diameter less than 3 μm, and a length-to-width ratio (aspect ratio) of at least 3:1.
  3. #Targeted fiber number dose according to WHO guideline and TRGS 905.
  4. ##Actual fiber number dose; deviations from target values are due to inhomogeneities during successive synthesis or suspension of test items.
  5. ###Total mass dose per rat in mg of substance including also fibers shorter than WHO fibers.